Edgar Filing: SYNAPTICS INC

Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Barber Kevin D

2. Issuer Name and Ticker or Trading Symbol
SYNAPTICS INC [SYNA]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
SVP & GM, Handheld Products

(Last)

(First)

(Middle)

1251 MCKAY DRIVE

3. Date of Earliest Transaction (Month/Day/Year)
04/24/2015

(Street)

SAN JOSE, CA 95131

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/27/2015		M		2,448	A	$ 23.16	7,117	D
Common Stock	04/27/2015		M		36,398	A	$ 27.99	43,515	D
Common Stock	04/27/2015		M		6,198	A	$ 32.53	49,713	D
Common Stock	04/27/2015		M		4,243	A	$ 35.76	53,956	D
Common Stock	04/27/2015		M		3,263	A	$ 39.8	57,219	D
Common Stock	04/27/2015		M		3,753	A	$ 42.57	60,972	D
Common Stock	04/27/2015		M		2,802	A	$ 46.5	63,774	D
Common Stock	04/27/2015		M		2,802	A	$ 60.22	66,576	D
Common Stock	04/27/2015		M		1,681	A	$ 61.4	68,257	D
Common Stock	04/27/2015		S⁽¹⁾		60,612	D	$ 85.0363 ⁽²⁾	7,645	D
Common Stock	04/27/2015		S⁽¹⁾		2,976	D	$ 85.6909 ⁽³⁾	4,669	D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Employee Stock Option (Right to Buy)

$ 85.69

04/24/2015

4,725

⁽⁴⁾

04/24/2022

Common Stock

4,725

$ 0

4,725

Employee Stock Option (Right to Buy)

$ 23.16

04/27/2015

2,448

⁽⁵⁾

10/31/2019

Common Stock

2,448

$ 0

1,143

Employee Stock Option (Right to Buy)

$ 27.99

04/27/2015

36,398

⁽⁶⁾

01/24/2018

Common Stock

36,398

$ 0

Employee Stock Option (Right to Buy)

$ 32.53

04/27/2015

6,198

⁽⁷⁾

10/24/2018

Common Stock

6,198

$ 0

2,188

Employee Stock Option (Right to Buy)

$ 35.76

04/27/2015

4,243

⁽⁸⁾

01/28/2020

Common Stock

4,243

$ 0

1,632

Employee Stock Option (Right to Buy)

$ 39.8

04/27/2015

3,263

⁽⁹⁾

08/05/2020

Common Stock

3,263

$ 0

2,612

Employee Stock Option (Right to Buy)

$ 42.57

04/27/2015

3,753

⁽¹⁰⁾

04/29/2020

Common Stock

3,753

$ 0

2,122

Employee Stock Option (Right to Buy)

$ 46.5

04/27/2015

2,802

⁽¹¹⁾

10/28/2020

Common Stock

2,802

$ 0

3,923

Employee Stock Option (Right to Buy)

$ 60.22

04/27/2015

2,802

⁽¹²⁾

01/27/2021

Common Stock

2,802

$ 0

3,923

Employee Stock Option (Right to Buy)

$ 61.4

04/27/2015

1,681

⁽¹³⁾

04/28/2021

Common Stock

1,681

$ 0

5,044

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Barber Kevin D 1251 MCKAY DRIVE SAN JOSE, CA 95131			SVP & GM, Handheld Products

Signatures

Kermit Nolan, as attorney-in-fact		04/28/2015
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The shares were sold pursuant to a 10b5-1 Sales Plan dated February 28, 2015.
(2)	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.50 to $85.47, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
(3)	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.55 to $85.91, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
(4)	1/12th of the total number of shares subject to the option shall vest and become exercisable each quarter following the April 24, 2015 date of grant, until fully vested on April 24, 2018.
(5)	1/36th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable on the last day of each month following the date of grant until fully vested on October 31, 2015.
(6)	25% of the total number of shares subject to the option vested and became exercisable on the twelve month anniversary of the January 24, 2011 date of grant, and 1/48th of the total number of shares subject to the option vested and became exercisable on the 24th day of each month thereafter until fully vested on January 24, 2015.
(7)	1/48th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable on the 24th day of each month after the October 24, 2011 date of grant until fully vested on October 24, 2015.
(8)	1/36th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable on the 28th day of each month following the date of grant until fully vested on January 28, 2016.
(9)	1/36th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable on the 5th day of each month following the date of grant until fully vested on August 5, 2016.
(10)	1/36th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable on the 29th day of each month following the date of grant until fully vested on April 29, 2016
(11)	1/12th of the total number of shares subject to the options vested or shall vest and became or shall become exercisable each quarter following the October 28, 2013 grant date until fully vested on October 28, 2016.
(12)	1/12th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable each quarter following the January 27, 2014 date of grant, until fully vested on January 27, 2017.
(13)	1/12th of the total number of shares subject to the option vested or shall vest and became or shall become exercisable each quarter following the April 28, 2014 date of grant, until fully vested on April 28, 2017.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.